News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

Are New Zealand & Australia ready for new cancer therapies?

31 July 2013

Are New Zealand & Australia ready for new cancer therapies?

Medicines New Zealand welcomes the report ‘Access to Cancer Medicines in Australia’, and calls for a similar stakeholder discussion to occur in New Zealand.

The report generated by Deloitte Access Economics, was presented at todays’ Medical Oncology Group Australia (MOGA) Annual Scientific Meeting in Melbourne. It highlights the significant burden of disease that cancer presents, and highlights disparities around investment in the Australian health system. For example, cancer receiving only 13% of health funding despite it representing 20% of disease burden. The report also highlights that significant advances are being made in research and development of new cancer medicines, but obtaining timely, equitable and fair access to new cancer treatments is going to be a challenge.

“This new report is valuable and many of the key conclusions can equally apply to New Zealand”, said Kevin Sheehy, General Manager of Medicines New Zealand.

Cancer is a major health issue for New Zealanders, and one in three New Zealanders will have some experience of cancer, either personally or through a relative or friend. Like Australia, cancer is New Zealand’s leading cause of death (29 percent) and a major cause of hospitalisation.

Reducing the burden of cancer in the New Zealand community is also one of the Government’s priority areas as our rate of cancer is likely to grow with the ageing population.

International comparison of estimated incidence of all cancers, 2008


Click for big version.

Source: Ferlay et al 2010, cited in AIHW & AACR 2012

“The New Zealand Ministry of Health’s National Cancer Programme has the goal of better, sooner and more convenient cancer care, and this is to be commended. Particularly as it has a specific goal for timely access to chemotherapy. However it does not address the key issue of whether NZ is getting timely to the best treatments that are now available.” says Sheehy.

Unfortunately, the lack of medicines budget available to PHARMAC has not allowed NZ to remain up to date with the latest advances in medicine while our total health spend remains in the top 10 OECD countries. Cancer therapies are no exception.

Breast cancer patient advocacy group, the Breast Cancer Aotearoa Coalition, agrees that more needs to be done to ensure New Zealanders have ready access to new cancer medicines.

BCAC chair, Libby Burgess, says the Deloitte’s report notes many Australian stakeholders are concerned that new cancer medicines are introduced much later there than they are in the US and Europe.

“The situation is far worse in New Zealand, where on average we see new medicines introduced some three-and-a-half years after Australia. This means New Zealanders are waiting far too long for treatments which could save lives,” Ms Burgess says.

The report questions the way medicines subsidies are evaluated and assessed in Australia and Ms Burgess says a similar evaluation needs to be undertaken in New Zealand.

Some stakeholders noted that the Australian reimbursement system, first implemented 20 years ago for determining the value for money of medicines, has not adapted sufficiently to the changes in the development of medicines and diagnostic technologies, particularly in regard to targeted cancer medicines. Many components of the current process are not fit for purpose to meet the emerging issues associated with cancer medicines.

The Deloitte’s report recommends “procedural improvements by streamlining the complex and lengthy regulatory and reimbursement processes” in Australia.

Ms Burgess says similar ‘procedural improvements’ are needed in New Zealand to ensure that new medicines are evaluated quickly and subsidised in a timely manner to truly benefit the health of country. BCAC is hopeful that PHARMAC’s current consultation on its Operating Policies and Procedures will lead to faster more transparent decisions and access to a wider range of effective medicines.

ENDS

© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
Obituary: Whānau Announce The Passing Of Bruce Stewart QSM

Matua Bruce was an award-winning builder before he embarked on a journey to build Tapu Te Ranga Marae in 1974... He built Tapu Te Ranga Marae from recycled material with just $25 and a dream. More>>

ALSO:

Gordon Campbell: On The America’s Cup

The fact New Zealand now reigns supreme once again in the most sophisticated contest in the world’s most elite sport – yacht racing – can’t help but reflect the trajectory the country has been on since the 1980s... More>>

ALSO:

Howard Davis: Christopher Marlowe & 'The Tragedy Of Dr. Faustus'

Previous versions of 'The Devil's Pact' can be traced back to the fourth century, Marlowe deviated significantly by depicting his protagonist as unable to burn his books or repent to a merciful God in order to have his contract annulled... More>>

ALSO:

Gold For RNZ: Muslim Post-9/11 Series, Kim Hill Win In New York

The Radio New Zealand podcast series Public Enemy has won a gold award for excellence for its presenter, Mohamed Hassan, at the prestigious New York Festival Radio Awards announced in Manhattan today. RNZ National’s Saturday Morning host, Kim Hill, also received a gold award for Best Radio Personality. More>>

Human Rights Commission: Give Nothing To Racism

A campaign urging New Zealanders to give nothing to racism and refuse to spread intolerance has been launched by some of the country’s most well-known people. More>>

Louis Vuitton Series Win: Emirates Team NZ Will Challenge For The America’s Cup

By beating Artemis 5-2 they now take on Oracle Team USA in the America’s Cup match starting next weekend. More>>

ALSO:

 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland